NHS Pharmacy Rules 2026: What Changes in England

If you use a community pharmacy in England, these new NHS rules are worth knowing about even though the legal title is a mouthful. The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2026 were made on 2 September 2026, laid before Parliament on 3 September 2026, and most of the changes start on 1 October 2026. The text on legislation.gov.uk says the instrument applies in relation to England, even though it formally extends to England and Wales. Most patients will not notice a dramatic overnight shift, but pharmacies, prescribers and NHS England will be working under tighter rules on consent, prescribing, staffing checks and short training closures.

One of the clearest patient-facing changes is about your nominated dispensing contractor, which is the pharmacy recorded in your NHS Patient Demographics Service, usually shortened to PDS, for dispensing. Under the amended terms of service, a pharmacy must not add or change that choice without the person's explicit consent, or the explicit consent of a duly authorised representative. The same protection is also written into the rules for Local Pharmaceutical Services, often called LPS, which are pharmacies working under a different NHS contract model. **What this means for you:** if your nominated pharmacy is entered or changed, that should now be tied more clearly to an active yes rather than assumption or convenience. In simple terms, the rule is there to stop quiet switches and make sure the pharmacy listed in NHS records is the one the patient has actually agreed to use.

The biggest practice change for many pharmacists sits in new regulation 66A. It says an NHS pharmacist must not provide a drug or appliance on a prescription written by a prescriber who is employed or engaged by that same pharmacy, unless specific exceptions apply. That may sound technical, but the principle is straightforward: the rules are trying to put firmer boundaries around situations where prescribing and dispensing happen within the same business. There are two routes where this can still happen. The first is when the supply is part of a directed service and the terms of that service expressly allow it. The second, and much narrower, route is within an essential service, where several safeguards have to be in place, including standard operating procedures, electronic prescribing, agreement from the primary medical services provider when an existing order is being replaced, and a best interests assessment by the prescriber before the order is made.

That best interests test is spelled out unusually clearly in the regulations. The prescriber has to decide that the order is clinically appropriate for the patient, represents good value for the health service, and is professionally appropriate in every other respect. The regulations also say the essential-service exception only works where the pharmacy already provides a directed service that entitles that prescriber to order medicines or appliances on a prescription form, and the order must be electronic and for a prescription-only medicine whose ordering is not restricted under the Prescription of Drugs Regulations. **Why this matters:** this is partly about patient safety and partly about incentives. If NHS England believes a pharmacy has supplied a medicine or appliance outside those rules, the regulations say no pharmaceutical remuneration is payable for that supply. So this is not just advisory wording. It creates a financial and contractual consequence too.

Another practical change is more human. Schedule 4 now allows a pharmacy to be treated as open for up to four hours in each calendar month when it is actually closed for learning and development, so long as strict conditions are met. The pharmacy must tell NHS England at least 30 days in advance, NHS England must not object, local GP providers used to sending patients there must be told, and the closure has to be shown in the NHS directory of services and on the NHS.uk website. Where possible, the pharmacy must also display a notice outside, or on its public website if it is a distance-selling pharmacy. There are important limits. These closures cannot take place on Saturdays or Sundays, within three hours of the start of opening on the first weekday of opening, within three hours of the end of opening on the last weekday of opening, or, for pharmacies with a current or historic 100 hours condition, between 5pm and 9pm on a weekday. NHS England can object if the closure, taken with other local gaps, would cause avoidable disruption to pharmaceutical services in the area.

**What this means in everyday life:** you may occasionally find your pharmacy shut for a short training session and still classed as meeting its contractual opening hours, but only within a tightly controlled window. The idea is to make room for learning without leaving whole areas short of access. That matters because pharmacies are expected to keep staff skills current while still offering reliable local care. A further safeguarding change arrives later. From 1 January 2027, professional staff and locums involved in pharmaceutical services must have either a valid enhanced DBS certificate, treated as valid for three years from issue, or evidence of an enhanced DBS status check through the DBS Update Service. The same requirement is added for LPS contractors. For patients, that is mainly about reassurance. For pharmacy owners, it means a clearer compliance duty around recruitment and record-keeping.

Some of the amendments are less visible to the public but still matter for how the system runs. The regulations now spell out that co-operating in a local dispute includes answering NHS England's reasonable questions and providing reasonably requested information within the timescales it sets. They also make clear that a provider's failure to co-operate can count against them when NHS England decides whether it must undertake or continue local dispute resolution before moving towards remedial or breach action. The paperwork is also trimmed in a few places. The explanatory note on legislation.gov.uk says applicants no longer have to provide certain extra information where an application relates to directed services, and routine or excepted applications for inclusion in a pharmaceutical list no longer need to state the applicant's sex. These are smaller changes, but they show a familiar pattern: less unnecessary form-filling, paired with clearer duties where governance and accountability are involved.

If ownership of a pharmacy changes but the business is not relocating, the rules also relax one technical refusal ground linked to the same or adjacent premises. In plain English, a straightforward change of ownership should not be blocked automatically just because the premises sit on the same site as an existing provider. Separate amendments also let NHS England skip advance notification in certain dispensing-doctor applications where the law already requires refusal, while still notifying the relevant people once the decision has been made. The explanatory note says no full impact assessment was prepared because the Government does not expect a significant effect on the public sector and sees only a limited private-sector impact. Even so, these are not empty tidy-ups. Taken together, the amendments give patients a stronger say over pharmacy choice, give NHS England firmer rules for oversight and disputes, and give pharmacies a more explicit rulebook on prescribing, training time and safeguarding. If you work in community pharmacy, 1 October 2026 is the main date to prepare for, with the DBS requirement following on 1 January 2027.